Background: Deep brain stimulation (DBS) of either the globus pallidus interna (GPi) or subthalamic nucleus (STN) is similarly effective for treating somatomotor manifestations of Parkinson’s disease (PD), but differences in how stimulation of each target affects oculomotor function are poorly understood. Objective: We sought to determine if stimulation of the STN, but not the GPi, affects oculomotor function in PD patients. Methods: Nineteen PD patients with DBS implants (8 bilateral GPi, 9 bilateral STN and 2 unilateral STN) were studied. Testing was performed with stimulation on, then off. Somatomotor function was tested using the Unified Parkinson’s Disease Rating Scale (UPDRS) motor exam. For oculomotor testing, patients performed pro- and antisaccade tasks while monitored with an infrared eye tracker. Saccadic latency, saccadic intrusions, and square-wave jerks (SWJs) were measured for each trial. Results: As expected, UPDRS motor scores improved with both GPi and STN stimulation. With GPi stimulation, there was no significant difference in oculomotor function with stimulation on or off. However, with STN stimulation on, there was a significant increase in the mean number of SWJs/s, as well as a significant decrease in latency for both pro- and antisaccade tasks. Conclusion: Stimulation of either GPi or STN had similar effects on somatomotor function, but only STN stimulation significantly altered oculomotor function.

Keywords:
Deep brain stimulation, Parkinson’s disease, Subthalamic nucleus, Globus pallidus
1.
Jankovic J: Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008;79:368–376.
2.
Growdon JH, Kieburtz K, McDermott MP, Panisset M, Friedman JH: Levodopa improves motor function without impairing cognition in mild non-demented Parkinson’s disease patients. Parkinson study group. Neurology 1998;50:1327–1331.
3.
Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, Marks WJ Jr, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein JM, Stoner G, Starr PA, Simpson R, Baltuch G, De Salles A, Huang GD, Reda DJ: Pallidal versus subthalamic deep-brain stimulation for Parkinson’s disease. N Engl J Med 2010;362:2077–2091.
4.
Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ Jr, Rothlind J, Sagher O, Reda D, Moy CS, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein J, Stoner G, Heemskerk J, Huang GD: Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009;301:63–73.
5.
Hood AJ, Amador SC, Cain AE, Briand KA, Al-Refai AH, Schiess MC, Sereno AB: Levodopa slows prosaccades and improves antisaccades: an eye movement study in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2007;78:565–570.
6.
O’Sullivan JD, Maruff P, Tyler P, Peppard RF, McNeill P, Currie J: Unilateral pallidotomy for Parkinson’s disease disrupts ocular fixation. J Clin Neurosci 2003;10:181–185.
7.
Yugeta A, Terao Y, Fukuda H, Hikosaka O, Yokochi F, Okiyama R, Taniguchi M, Takahashi H, Hamada I, Hanajima R, Ugawa Y: Effects of STN stimulation on the initiation and inhibition of saccade in Parkinson disease. Neurology 2010;74:743–748.
8.
Eskandar EN, Flaherty A, Cosgrove GR, Shinobu LA, Barker FG 2nd: Surgery for Parkinson disease in the United States, 1996 to 2000: practice patterns, short-term outcomes, and hospital charges in a nationwide sample. J Neurosurg 2003;99:863–871.
9.
Obeso JA, Rodriguez-Oroz MC, Benitez-Temino B, Blesa FJ, Guridi J, Marin C, Rodriguez M: Functional organization of the basal ganglia: therapeutic implications for Parkinson’s disease. Mov Disord 2008;23(suppl 3):S548–S559.
10.
Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schafer H, Botzel K, Daniels C, Deutschlander A, Dillmann U, Eisner W, Gruber D, Hamel W, Herzog J, Hilker R, Klebe S, Kloss M, Koy J, Krause M, Kupsch A, Lorenz D, Lorenzl S, Mehdorn HM, Moringlane JR, Oertel W, Pinsker MO, Reichmann H, Reuss A, Schneider GH, Schnitzler A, Steude U, Sturm V, Timmermann L, Tronnier V, Trottenberg T, Wojtecki L, Wolf E, Poewe W, Voges J: A randomized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med 2006;355:896–908.
11.
Hikosaka O, Takikawa Y, Kawagoe R: Role of the basal ganglia in the control of purposive saccadic eye movements. Physiol Rev 2000;80:953–978.
12.
Parent A, Hazrati LN: Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev 1995;20:128–154.
13.
Temperli P, Ghika J, Villemure JG, Burkhard PR, Bogousslavsky J, Vingerhoets FJ: How do parkinsonian signs return after discontinuation of subthalamic DBS? Neurology 2003;60:78–81.
14.
Lopiano L, Torre E, Benedetti F, Bergamasco B, Perozzo P, Pollo A, Rizzone M, Tavella A, Lanotte M: Temporal changes in movement time during the switch of the stimulators in Parkinson’s disease patients treated by subthalamic nucleus stimulation. Eur Neurol 2003;50:94–99.
15.
Leigh RJ, Zee DS: The Neurology of Eye Movements, ed 4. New York, Oxford University Press, 2006.
16.
Abadi RV, Gowen E: Characteristics of saccadic intrusions. Vision Res 2004;44:2675–2690.
17.
Shallo-Hoffmann J, Sendler B, Muhlendyck H: Normal square wave jerks in differing age groups. Invest Ophthalmol Vis Sci 1990;31:1649–1652.
18.
Nutt JG, Rufener SL, Carter JH, Anderson VC, Pahwa R, Hammerstad JP, Burchiel KJ: Interactions between deep brain stimulation and levodopa in Parkinson’s disease. Neurology 2001;57:1835–1842.
19.
Michell AW, Xu Z, Fritz D, Lewis SJ, Foltynie T, Williams-Gray CH, Robbins TW, Carpenter RH, Barker RA: Saccadic latency distributions in Parkinson’s disease and the effects of L-dopa. Exp Brain Res 2006;174:7–18.
20.
Rascol O, Sabatini U, Simonetta-Moreau M, Montastruc JL, Rascol A, Clanet M: Square wave jerks in parkinsonian syndromes. J Neurol Neurosurg Psychiatry 1991;54:599–602.
21.
White OB, Saint-Cyr JA, Tomlinson RD, Sharpe JA: Ocular motor deficits in Parkinson’s disease. II. Control of the saccadic and smooth pursuit systems. Brain 1983;106(pt 3):571–587.
22.
Pinnock RA, McGivern RC, Forbes R, Gibson JM: An exploration of ocular fixation in Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy. J Neurol 2010;257:533–539.
23.
Averbuch-Heller L, Stahl JS, Hlavin ML, Leigh RJ: Square-wave jerks induced by pallidotomy in parkinsonian patients. Neurology 1999;52:185–188.
24.
Wark HA, Garell PC, Walker AL, Basso MA: A case report on fixation instability in Parkinson’s disease with bilateral deep brain stimulation implants. J Neurol Neurosurg Psychiatry 2008;79:443–447.
25.
Parent A, Hazrati LN: Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev 1995;20:91–127.
26.
Hikosaka O, Wurtz RH: Visual and oculomotor functions of monkey substantia nigra pars reticulata. IV. Relation of substantia nigra to superior colliculus. J Neurophysiol 1983;49:1285–1301.
27.
Shin S, Sommer MA: Activity of neurons in monkey globus pallidus during oculomotor behavior compared with that in substantia nigra pars reticulata. J Neurophysiol 2010;103:1874–1887.
28.
Yoshida A, Tanaka M: Enhanced modulation of neuronal activity during antisaccades in the primate globus pallidus. Cereb Cortex 2009;19:206–217.
29.
Blekher T, Siemers E, Abel LA, Yee RD: Eye movements in Parkinson’s disease: before and after pallidotomy. Invest Ophthalmol Vis Sci 2000;41:2177–2183.
30.
Fawcett AP, Moro E, Lang AE, Lozano AM, Hutchison WD: Pallidal deep brain stimulation influences both reflexive and voluntary saccades in Huntington’s disease. Mov Disord 2005;20:371–377.
31.
Straube A, Ditterich J, Oertel W, Kupsch A: Electrical stimulation of the posteroventral pallidum influences internally guided saccades in Parkinson’s disease. J Neurol 1998;245:101–105.
32.
Fawcett AP, Dostrovsky JO, Lozano AM, Hutchison WD: Eye movement-related responses of neurons in human subthalamic nucleus. Exp Brain Res 2005;162:357–365.
33.
Matsumura M, Kojima J, Gardiner TW, Hikosaka O: Visual and oculomotor functions of monkey subthalamic nucleus. J Neurophysiol 1992;67:1615–1632.
34.
Maltete D, Jodoin N, Karachi C, Houeto JL, Navarro S, Cornu P, Agid Y, Welter ML: Subthalamic stimulation and neuronal activity in the substantia nigra in Parkinson’s disease. J Neurophysiol 2007;97:4017–4022.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.